http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104693100-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_320d62d5a1756969b78279df21ba05c7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfbf7b8c245249b1cdf7c9c4d96df8a4
publicationDate 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104693100-A
titleOfInvention Bishydrazide and amidonaphthalene structure containing compound and use thereof
abstract The invention discloses a bishydrazide and amidonaphthalene structure containing compound and use thereof, relates to the field of venous thrombotic disease related drugs and particularly relates to an FXa inhibitor containing a bishydrazide and amido substituted naphthyl structure, a preparation method of the FXa inhibitor and an application of the FXa inhibitor in preparation of drugs for treating venous thrombotic diseases. The FXa inhibitor has a structure represented by a formula shown in descriptions.
priorityDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10280735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24648
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163753773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465432644
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592078
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443032
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID304917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415875234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409667724
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449682174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID204102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03352

Total number of triples: 40.